ZOLEDRONIC ACID

Zoledronic acid

Contents: each vial contains:

active substance: zoledronic acid (as zoledronic acid monohydrate) – 4 mg.

Therapeutic indications

Treatment of hypercalcemia caused by malignant tumor (at blood serum concentration of calcium adjusted by the albumin level >12 mg/ml or 3 mmole/l).

Treatment of patients with metastases in bones with malignant solid tumors and multiple myeloma in combination with standard antineoplastic therapy.

	АТС code
	М05ВА08
	Pharmaceutical form
	lyophilized powder for solution for infusion 4 mg
	Storage conditions
	Store in protected from light place at the temperature below 25ºС.